Biotage AB Forecast, price target & analysts
Biotage AB Target price 2025 - Analyst rating & recommendation
Biotage AB Classifications & Recommendation:
Biotage AB Price Target
| Target Price | SEK140.75 |
| Price | SEK141.80 |
| Deviation |
0.74%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Biotage AB 2026 .
The average Biotage AB target price is SEK140.75.
This is
0.74%
register free of charge
SEK145.00
2.26%
register free of charge
SEK135.00
4.80%
register free of charge
|
|
| A rating was issued by 3 analysts: 1 Analysts recommend Biotage AB to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Biotage AB stock has an average upside potential 2026 of
0.74%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion SEK | 2.06 | 1.98 |
| 9.83% | 3.57% | |
| EBITDA Margin | 26.26% | 25.05% |
| 5.06% | 4.09% | |
| Net Margin | 13.82% | 11.95% |
| 2.64% | 13.54% |
4 Analysts have issued a sales forecast Biotage AB 2025 . The average Biotage AB sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Biotage AB EBITDA forecast 2025. The average Biotage AB EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Biotage AB Analysts have issued a net profit forecast 2025. The average Biotage AB net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share SEK | 3.55 | 2.96 |
| 6.93% | 16.62% | |
| P/E | 47.91 | |
| EV/Sales | 5.63 |
4 Analysts have issued a Biotage AB forecast for earnings per share. The average Biotage AB EPS is
This results in the following potential growth metrics and future valuations:
Current Biotage AB Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Mar 19 2025 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 07 2024 |
| HANDELSBANKEN CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Oct 29 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Mar 19 2025 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 07 2024 |
|
Locked
HANDELSBANKEN CAPITAL MARKETS:
Locked
➜
Locked
|
Oct 29 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
